Clinical Trials for Genelux

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Genelux

Clinical Trials (2)

Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

PHASE2Recruiting

142 participants

Started: Sep 26, 2024 · Completed: Jul 31, 2029

8 conditions2 sponsors16 locations

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

PHASE3Recruiting

186 participants

Started: Aug 31, 2022 · Completed: Oct 31, 2026

7 conditions2 sponsors30 locations